Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Disorder

University Hospital, Brest39 enrolled

Overview

Substance use disorders (SUD) and attention deficit disorder with or without hyperactivity (ADHD) are frequently co-morbid, particularly among people under court supervision. The coexistence of these disorders increases the social and legal vulnerability of individuals. Better identification of ADHD in vulnerable people with SUD is essential to improving their care. This project aims to provide appropriate support for this at-risk population.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Attention Deficit Disorder With Hyperactivity (ADHD)Substance Use Disorder (SUD)

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult, under the supervision of the justice system or monitored by a correctional facility * Diagnosis of Substance Use Disorder (SUD) * Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) * No objection from the patient * Affiliated with a Social Security system Exclusion Criteria: * Severe or decompensated psychiatric disorders * Severe cognitive impairment * Lack of understanding of the French language * Refusal to participate

Outcomes

Primary Outcomes

80% of patients participated in the workshops

The primary outcome measure is the acceptability of the program to participants in the pilot workshops, gathered through: * Semi-structured pre- and post-intervention interviews * A Likert scale * Workshop participation rate (at least 80%)

Time frame: From enrollment to the end of wordshop at 6 months

Secondary Outcomes

SF-12 quality of life

The secondary outcome measure will be measured by the SF-12 quality of life, before and after the 5 workshops. The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life.